Medicare drug subsidy to end, raising costs for millions

The Trump administration is ending a temporary Medicare Part D subsidy program that has held down prescription drug premiums for two years. About 25 million beneficiaries could face higher monthly costs in 2027, with estimated average increases under $10 per month. The decision, announced by CMS, comes during a midterm election year when older voters – a key constituency – are focused on cost of living. Democrats have criticized the move as a healthcare affordability attack.